Dashboard
Manage Tickers

MNOV MEDICINOVA INC

Nasdaq medicinova.com


$ 1.21 $ 0.00 (0 %)    

Thursday, 23-Oct-2025 14:02:30 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 616.25 $ 0.00 (0 %)
DIA $ 469.65 $ 0.00 (0 %)
SPY $ 676.21 $ 0.00 (0 %)
TLT $ 91.62 $ 0.00 (0 %)
GLD $ 378.91 $ 0.00 (0 %)
$ 1.22
$ 1.22
$ 1.19 x 100
$ 1.28 x 100
-- - --
$ 1.13 - $ 2.55
24,914
na
59.84M
$ 0.47
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-14-2025 06-30-2025 10-Q
2 05-13-2025 03-31-2025 10-Q
3 02-19-2025 12-31-2024 10-K
4 11-13-2024 09-30-2024 10-Q
5 08-08-2024 06-30-2024 10-Q
6 05-09-2024 03-31-2024 10-Q
7 02-15-2024 12-31-2023 10-K
8 11-09-2023 09-30-2023 10-Q
9 08-09-2023 06-30-2023 10-Q
10 05-11-2023 03-31-2023 10-Q
11 02-16-2023 12-31-2022 10-K
12 11-10-2022 09-30-2022 10-Q
13 08-11-2022 06-30-2022 10-Q
14 05-12-2022 03-31-2022 10-Q
15 02-16-2022 12-31-2021 10-K
16 11-12-2021 09-30-2021 10-Q
17 08-12-2021 06-30-2021 10-Q
18 05-13-2021 03-31-2021 10-Q
19 02-19-2021 12-31-2020 10-K
20 10-26-2020 09-30-2020 10-Q
21 07-28-2020 06-30-2020 10-Q
22 04-23-2020 03-31-2020 10-Q
23 02-13-2020 12-31-2019 10-K
24 10-25-2019 09-30-2019 10-Q
25 07-25-2019 06-30-2019 10-Q
26 04-25-2019 03-31-2019 10-Q
27 02-13-2019 12-31-2018 10-K
28 10-25-2018 09-30-2018 10-Q
29 07-23-2018 06-30-2018 10-Q
30 04-25-2018 03-31-2018 10-Q
31 02-13-2018 12-31-2017 10-K
32 10-23-2017 09-30-2017 10-Q
33 07-26-2017 06-30-2017 10-Q
34 04-26-2017 03-31-2017 10-Q
35 02-14-2017 12-31-2016 10-K
36 10-25-2016 09-30-2016 10-Q
37 07-26-2016 06-30-2016 10-Q
38 04-27-2016 03-31-2016 10-Q
39 02-25-2016 12-31-2015 10-K
40 10-29-2015 09-30-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

d-boral-capital-maintains-buy-on-medicinova-maintains-9-price-target
D. Boral Capital Maintains Buy on MediciNo...
09/22/2025 14:11:04

D. Boral Capital analyst Jason Kolbert maintains MediciNova (NASDAQ:MNOV) with a Buy and maintains $9 price target.

medicinova-completes-patient-enrollment-in-phase-23-clinical-trial-combat-als-for-treatment-of-amyotrophic-lateral-sclerosis
MediciNova Completes Patient Enrollment In...
09/22/2025 12:09:53

MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the Standard Market of the T...

medicinova-issues-shareholder-update-secures-30m-sepa-to-advance-rd-as-combat-als-trial-hits-enrollment-target-nih-funded-eap-and-mn-001-diabetes-study-near-completion
MediciNova Issues Shareholder Update; Secu...
09/08/2025 13:12:03

MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the Standard Market of the T...

reported-earlier-medicinova-reaches-target-number-of-participants-in-combat-als-clinical-trial-across-sites-in-us-and-canada
Reported Earlier, MediciNova Reaches Targe...
08/27/2025 06:06:16

medicinova-files-prospectus-relates-to-offer-sale-of-up-to-25m-shares-of-common-stock-by-ya-ii-pn-ltd
MediciNova Files Prospectus Relates To Off...
08/22/2025 20:27:49

-SEC Filing

medicinova-q2-eps-007-beats-010-estimate-sales-134599k
MediciNova Q2 EPS $(0.07) Beats $(0.10) Es...
08/14/2025 21:57:17

MediciNova (NASDAQ:MNOV) reported quarterly losses of $(0.07) per share which beat the analyst consensus estimate of $(0.10) by...

reported-earlier-medicinova-announces-standby-equity-purchase-agreement-with-yorkville-advisors-for-up-to-30m-over-36-months
Reported Earlier, MediciNova Announces Sta...
08/01/2025 07:17:56

d-boral-capital-maintains-buy-on-medicinova-maintains-9-price-target
D. Boral Capital Maintains Buy on MediciNo...
07/24/2025 12:35:07

D. Boral Capital analyst Jason Kolbert maintains MediciNova (NASDAQ:MNOV) with a Buy and maintains $9 price target.

medicinova-nears-singledigit-randomization-in-phase23-combatals-trial-and-seeks-final-two-patients-in-phase2-dyslipidemiaandfattyliver-study
MEDICINOVA Nears Single‑Digit Randomizatio...
07/24/2025 10:10:07

b-riley-securities-maintains-buy-on-medicinova-lowers-price-target-to-5
B. Riley Securities Maintains Buy on Medic...
06/16/2025 17:34:51

B. Riley Securities analyst Mayank Mamtani maintains MediciNova (NASDAQ:MNOV) with a Buy and lowers the price target from $6...

medicinova-q1-eps-006-beats-014-estimate
MediciNova Q1 EPS $(0.06) Beats $(0.14) Es...
05/13/2025 21:53:04

MediciNova (NASDAQ:MNOV) reported quarterly losses of $(0.06) per share which beat the analyst consensus estimate of $(0.14) by...

d-boral-capital-maintains-buy-on-medicinova-maintains-9-price-target
D. Boral Capital Maintains Buy on MediciNo...
04/09/2025 11:16:42

D. Boral Capital analyst Jason Kolbert maintains MediciNova (NASDAQ:MNOV) with a Buy and maintains $9 price target.

reported-earlier-medicinova-announces-first-enrollment-in-nih-supported-eap-trial-to-assess-mn-166-in-advanced-als-patients
Reported Earlier, MediciNova Announces Fir...
04/09/2025 07:22:07

This significant milestone marks the beginning of a critical trial aimed at providing access to MN-166 for ALS patients who are...

d-boral-capital-maintains-buy-on-medicinova-maintains-9-price-target
D. Boral Capital Maintains Buy on MediciNo...
03/14/2025 11:37:28

D. Boral Capital analyst Jason Kolbert maintains MediciNova (NASDAQ:MNOV) with a Buy and maintains $9 price target.

d-boral-capital-maintains-buy-on-medicinova-maintains-9-price-target
D. Boral Capital Maintains Buy on MediciNo...
02/21/2025 12:25:40

D. Boral Capital analyst Jason Kolbert maintains MediciNova (NASDAQ:MNOV) with a Buy and maintains $9 price target.

d-boral-capital-maintains-buy-on-medicinova-maintains-9-price-target
D. Boral Capital Maintains Buy on MediciNo...
12/06/2024 12:09:56

D. Boral Capital analyst Jason Kolbert maintains MediciNova (NASDAQ:MNOV) with a Buy and maintains $9 price target.

medicinova-presents-study-update-and-interim-analysis-of-phase-23-clinical-trial-of-mn-166-in-als-at-the-35th-international-symposium-on-alsmnd
MediciNova Presents Study Update And Inter...
12/05/2024 23:04:29

MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the Standard Market of the T...

this-autodesk-analyst-begins-coverage-on-a-bullish-note-here-are-top-5-initiations-for-monday
This Autodesk Analyst Begins Coverage On A...
12/02/2024 13:56:09

d-boral-capital-initiates-coverage-on-medicinova-with-buy-rating-announces-price-target-of-9
D. Boral Capital Initiates Coverage On Med...
12/02/2024 13:30:53

D. Boral Capital analyst Jason Kolbert initiates coverage on MediciNova (NASDAQ:MNOV) with a Buy rating and announces Price ...

medicinova-highlights-strategic-focus-on-non-dilutive-funding-with-nih-funded-als-trial-and-canadian-long-covid-study-reports-strong-423m-cash-position-and-reaffirms-commitment-to-sustainable-growth-and-shareholder-transparency
MediciNova Highlights Strategic Focus On N...
11/19/2024 14:17:53

To our esteemed stockholders,Since its founding, MediciNova has been clear in its mission to deliver new treatment options to t...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION